With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
In the fall of next year, the long anticipated EU Foreign Direct Investment Screening Regulation will apply. The regulation is likely to have a significant impact on FDI within the EU – both within Member States that ...
The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction of biosimilars on the competition between TNF alfa inhibitors. TNF-alfa inhibitors are biological medicines that ...
On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...
International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...
International law firm Bird & Bird today announces the merger of its Baseline consulting arm with Valeocon Management Consulting, creating one of the largest management consultancy firms linked to an international law ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
Partner for a Day is your opportunity to gain insights into the work of a lawyer. You will get two days of legal training with workshops and cases in e.g. contract drafting and negotiation techniques.
Join us at this seminar where experienced professionals from Bird & Bird Singapore and RSM will share practical financial advice and legal insights into what business owners, corporate investors and entrepreneurs should take note of when managing an M&A.
Join our IP & Regulatory lawyers at @KNect365Law EU Pharma Law academy. Click here for more info:… https://t.co/Piya5iQATs
Partner @SallyShorthose will be hosting a panel on the 'Power of mentoring' at the @WorldIPReview upcoming… https://t.co/67IrC4iQVq
When do clinical trial consent disclosures render a patent invalid? https://t.co/7PjQvZoQfL https://t.co/Peg4Eg7mzI